Sof marja: 10x (TXG)

10xgenomics.com (TXG) grafik logotipi

10x Genomics, Inc. (TXG) logistikani optimallashtirish orqali tadqiqot institutlariga hujayralarni tahlil qilish uskunalarining barqaror yetkazib berilishini ta'minlaydi. Kompaniyaning texnologik yetakchiligi uning inqilobiy Xenium va Chromium tizimlari bilan mustahkamlanadi. Sof marginal savdo daromadi daromadli dinamikani namoyish etmoqda, bunda -10.80 ushbu ko'rsatkichning bugungi qiymatini ifodalaydi. Biznes daromadlari asbob-uskunalar sotuvi va laboratoriyalar uchun reagentlarning muntazam ta'minotiga asoslangan.

10xgenomics.com (TXG) - Sof foyda bo'yicha sotuv rentabelligi 04.07.2022dan 19.11.2026gacha

10x Genomics, Inc. - tahliliy kesimlar va asosiy koʻrsatkichlar (TXG)

- aksiya kursi va ekspertlarning narx prognozi:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning jamlanma tahlili:10xgenomics.com - TXG
10x tayyor mahsulotlari

Yuqori sifatli aktivlarni saralash uchun investorlar bozor shovqinlarini chetga surib, haqiqiy foyda generatsiyasi samaradorligiga e'tibor qaratishlari kerak. Ushbu metrika sof daromadning tushumga nisbatan ulushini o'lchaydi, bu esa 10x Genomics, Inc. (TXG) holatida sarflanadigan materiallarning yuqori marjasi orqali "razor-and-blade" modelining samaradorligini tasdiqlaydi, tarixiy sof marjalar esa ushbu biznes strategiyasining barqarorligini ko'rsatadi.

10x Genomics, Inc. raqobatchilari

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Intellia Therapeutics, Inc. (NTLA) - Sotuvning sof marjinal rentabelligi|Sof marja Stoke Therapeutics Inc|BLFS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi WVE (Wave Life Sciences Corp)|Kompaniya sotuv marjasi Maze Therapeutics Corp|Sionna Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|PRME (primemedicine.com) - Sof foyda marjasi|TSHA - Sof marja|QURE (uniQure) - Sotuvning sof rentabelligi|MeiraGTx Corp (MGTX) - Sof marja|Regenxbio - Sof foyda normasi|Sof marja solidbio.com|Sof marja ocugen.com OCGN|Sotuvning sof marjinal rentabelligi PACB|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX